ALGN · Align Technology, Inc.
Healthcare NMS United States aligntech.com ↗
BULLISH BUY
Val Gro Qua Mom Sta Cap P/S3.15 P/E Fwd P/E14.55 PEG0.93 52W –  RSI Target$210.29 (+16.8%) Beta1.67 Div
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies Tempe, United States 20,275 employees
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 54 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
2Bullish
1Bearish
0Neutral
▲ Bull Flag — Breakout after +11% pole — bullish continuation
▲ Inv. Head & Shoulders — Inv. H&S neckline ~$182.19 broken — major bullish reversal
▼ Bear Flag — Breakdown after -14% pole — bearish continuation

View overlays on the price chart via Chart tab → Pattern Overlays.

EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
75% 6/8 quarters
Wall Street Consensus
BUY
11
4
1
BuyHoldSell
Price Target Range
$210.29 +16.8% upside
Low $175 High $240
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
BMO Capital Outperform ● Initiate 2026-07-09
Evercore ISI Group Outperform ↔ Maintain 2026-04-30
Morgan Stanley Equal-Weight ↔ Maintain 2026-04-24
Piper Sandler Overweight ↔ Maintain 2026-04-21
Citigroup Buy ● Initiate 2026-04-15
Barclays Overweight Equal-Weight Overweight ▲ Upgrade 2026-03-17
HSBC Buy Hold Buy ▲ Upgrade 2026-02-09
Stifel Buy ↔ Maintain 2026-02-05
UBS Neutral ↔ Maintain 2026-02-05
Wells Fargo Overweight ↔ Maintain 2026-02-05
Mizuho Outperform ↔ Maintain 2026-01-20
BMO Capital 2026-07-09
Outperform ● Initiate
Evercore ISI Group 2026-04-30
Outperform ↔ Maintain
Morgan Stanley 2026-04-24
Equal-Weight ↔ Maintain
Piper Sandler 2026-04-21
Overweight ↔ Maintain
Citigroup 2026-04-15
Buy ● Initiate
Barclays 2026-03-17
Overweight (from Equal-Weight) ▲ Upgrade
HSBC 2026-02-09
Buy (from Hold) ▲ Upgrade
Stifel 2026-02-05
Buy ↔ Maintain
UBS 2026-02-05
Neutral ↔ Maintain
Wells Fargo 2026-02-05
Overweight ↔ Maintain
Mizuho 2026-01-20
Outperform ↔ Maintain
Profitability
Gross Margin 69.91%TTM
Op. Margin 15.47%TTM
ROE 10.82%TTM
Rev. Growth 6.20%YoY
Free Cash Flow 532.95MTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 2.80MRQ
Current Ratio 1.39MRQ
Cash 1.06BMRQ
Total Debt 116.04MMRQ
Net Debt MRQ
How ALGN Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap12.90B
Enterprise Value11.95B
Trailing P/E30.27
Forward P/E14.55
PEG Ratio (5yr)0.93
Price/Sales (ttm)3.15
Price/Book (mrq)3.11
EV/Revenue2.92
EV/EBITDA13.57
Share Statistics
Avg Vol (3m)1.00M
Shares Outstanding71.62M
Float67.02M
% Held by Insiders6.82%
% Held by Institutions100.70%
Short Ratio4.52
Short % of Float7.69%
Profitability
Gross Margin69.91%
Operating Margin (ttm)15.47%
Profit Margin10.50%
Return on Assets (ttm)7.23%
Return on Equity (ttm)10.82%
Income Statement
Revenue (ttm)4.10B
Revenue Growth (yoy)6.20%
Gross Profit (ttm)2.86B
EBITDA880.81M
Net Income (ttm)429.89M
Diluted EPS (ttm)5.95
EPS Growth (yoy)23.90%
Balance Sheet
Total Cash (mrq)1.06B
Total Debt (mrq)116.04M
Debt / Equity (mrq)2.80
Current Ratio (mrq)1.39
Book Value / Share57.94
Operating CF (ttm)691.59M
Free Cash Flow (ttm)532.95M
Trading & Dividends
Beta (5Y)1.67
50-Day MA172.72
200-Day MA166.03
Fwd Dividend YieldN/A
Payout Ratio0.00%
Ownership Breakdown
Institutional 100.70% Insider 6.82%
Short Interest 7.69% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in ALGN in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-05-20 LACOB JOSEPH S Director 1,745
2026-05-20 SIEGEL SUSAN E Director 1,745
2026-05-20 LARKIN CHARLES RAYMOND JR Director 2,326
2026-05-20 MORROW GEORGE J Director 1,745
2026-05-20 SAIA ANDREA LYNN Director 1,745
2026-05-20 CONROY KEVIN T Director 1,745
2026-05-20 DALLAS KEVIN J. Director 1,745
2026-05-20 POUL MOJDEH Director 1,745
2026-05-20 VITALONE BRITT J Director 1,443
2026-05-20 MYONG ANNE Director 1,745
2026-02-20 HOGAN JOSEPH M Chief Executive Officer 40,248
2026-02-20 COLETTI JULIE ANN Officer 5,864
2026-02-20 HOCKRIDGE STUART A Officer 4,310
2026-02-20 MORICI JOHN Chief Financial Officer 7,848
2026-02-18 MORICI JOHN Chief Financial Officer Sale at price 189.31 per share. 7,969 $1,508,646
2025-08-01 HOGAN JOSEPH M Chief Executive Officer Purchase at price 131.49 per share. 7,576 $996,131
2025-05-21 LACOB JOSEPH S Director 1,148
2025-05-21 SIEGEL SUSAN E Director 1,148
2025-05-21 LARKIN CHARLES RAYMOND JR Director Conversion of Exercise of derivative security at price 0.00 per share. 1,531
2025-05-21 MORROW GEORGE J Director Conversion of Exercise of derivative security at price 0.00 per share. 1,148
2025-05-21 SAIA ANDREA LYNN Director Conversion of Exercise of derivative security at price 0.00 per share. 1,148
2025-05-21 CONROY KEVIN T Director 1,148
2025-05-21 DALLAS KEVIN J. Director Conversion of Exercise of derivative security at price 0.00 per share. 1,148
2025-05-21 POUL MOJDEH Director Conversion of Exercise of derivative security at price 0.00 per share. 1,148
2025-05-21 MYONG ANNE Director 1,148
LACOB JOSEPH S Director
2026-05-20 1,745 sh
SIEGEL SUSAN E Director
2026-05-20 1,745 sh
LARKIN CHARLES RAYMOND JR Director
2026-05-20 2,326 sh
MORROW GEORGE J Director
2026-05-20 1,745 sh
SAIA ANDREA LYNN Director
2026-05-20 1,745 sh
CONROY KEVIN T Director
2026-05-20 1,745 sh
DALLAS KEVIN J. Director
2026-05-20 1,745 sh
POUL MOJDEH Director
2026-05-20 1,745 sh
VITALONE BRITT J Director
2026-05-20 1,443 sh
MYONG ANNE Director
2026-05-20 1,745 sh
HOGAN JOSEPH M Chief Executive Officer
2026-02-20 40,248 sh
COLETTI JULIE ANN Officer
2026-02-20 5,864 sh
HOCKRIDGE STUART A Officer
2026-02-20 4,310 sh
MORICI JOHN Chief Financial Officer
2026-02-20 7,848 sh
MORICI JOHN Chief Financial Officer
Sale at price 189.31 per share.
2026-02-18 7,969 sh $1,508,646
HOGAN JOSEPH M Chief Executive Officer
Purchase at price 131.49 per share.
2025-08-01 7,576 sh $996,131
LACOB JOSEPH S Director
2025-05-21 1,148 sh
SIEGEL SUSAN E Director
2025-05-21 1,148 sh
LARKIN CHARLES RAYMOND JR Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21 1,531 sh
MORROW GEORGE J Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21 1,148 sh
SAIA ANDREA LYNN Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21 1,148 sh
CONROY KEVIN T Director
2025-05-21 1,148 sh
DALLAS KEVIN J. Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21 1,148 sh
POUL MOJDEH Director
Conversion of Exercise of derivative security at price 0.00 per share.
2025-05-21 1,148 sh
MYONG ANNE Director
2025-05-21 1,148 sh